Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by G7 Countries: Proportion of Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) to Hematological Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profile Snapshots 27
Appendix 36
Abbreviations 36
Definitions 36
Research Methodology 37
Secondary Research 37
About GlobalData 38
Contact Us 38
Source 38

List of Tables
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, Global, Clinical Trials by Region, 2017* 7
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 11
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
Proportion of Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2017* 16
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, Global, Clinical Trials by Phase, 2017* 19
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 23
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 26

List of Figures
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Proportion of Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2017* 15
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 20
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 21
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 22
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 23
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 24
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 25
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 26
GlobalData Methodology 37

Companies Mentioned
- CSL Ltd
- Bristol-Myers Squibb Company
- The Novo Nordisk Foundation
- Parexel International Corp